Reply to combination of gemcitabine and cisplatin is highly active in women with endometrial carcinoma: Results of a prospective phase 2 trial

Jubilee Brown, Judith K. Wolf, Judith A. Smith

Research output: Contribution to journal › Letter › peer-review

Fingerprint

Dive into the research topics of 'Reply to combination of gemcitabine and cisplatin is highly active in women with endometrial carcinoma: Results of a prospective phase 2 trial'. Together they form a unique fingerprint.